DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr | ₹1,950 Cr |
What is the latest Consolidated Net Profit of DR REDDYS LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹4,507 Cr |
Mar2023 | ₹2,183 Cr |
Mar2022 | ₹1,952 Cr |
Mar2021 | ₹2,026 Cr |
Mar2020 | ₹1,950 Cr |
How is Consolidated Net Profit of DR REDDYS LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹4,507 Cr | 106.52 | |
Mar2023 | ₹2,183 Cr | 11.83 | |
Mar2022 | ₹1,952 Cr | -3.67 | |
Mar2021 | ₹2,026 Cr | 3.90 | |
Mar2020 | ₹1,950 Cr | - |
Compare Consolidated Net Profit of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹108,598.5 Cr | -2.3% | -7.8% | 14.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,025.0 Cr | -0.4% | 4.7% | 60.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹144,299.0 Cr | -1.1% | 11% | 43.2% | Stock Analytics | |
CIPLA | ₹132,316.0 Cr | -1.3% | 2.8% | 33.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,092.0 Cr | -5.7% | -12.6% | 68.7% | Stock Analytics | |
MANKIND PHARMA | ₹97,396.6 Cr | -2.7% | 6.6% | 33.4% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -2.3% |
-7.8% |
14.4% |
SENSEX | 0.3% |
3% |
23.3% |
You may also like the below Video Courses